Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies

Immunology

Volumn 119, Issue 4, 2006, Pages 529-540

  Silvestre, Ricardo ^a,b,c   Cordeiro Da Silva, Anabela ^a,b   Tavares, Joana ^a,b,c   Sereno, Denis ^c   Ouaissi, Ali ^c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

B cells; Leishmania; Leishmaniasis; SIR2; Specific antibodies

Indexed keywords

CD69 ANTIGEN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; SILENT INFORMATION REGULATOR PROTEIN 2;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNIZATION; IN VITRO STUDY; LEISHMANIA INFANTUM; LEISHMANIASIS; LYMPHOCYTE FUNCTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COOPERATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SIRTUINS; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 33750853289     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02468.x     Document Type: Article

References (50)

1. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson WD. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986; 154:1003-11.
2. Ashford RW. Leishmaniasis reservoirs and their siginificance in control. Clin Dermatol 1996; 14:523-32.
3. Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol 1996; 14:417-23.
4. Carvalho EM, Teixeira RS, Johnson WD. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosupression during acute infection. Infect Immun 1981; 33:498-502.
5. Galvao-Castro B, Ferreira JAS, Marzochi KF, Marzochi MC, Coutinho SG, Lambert. PH. Polyclonal B cell activation, circulating immune complexes and autoimmunity in American visceral leishmaniasis. Clin Exp Immunol 1984; 56:58-66.
6. Bohme MW, Evans DA, Miles MA, Holborow EJ. Occurrence of autoantibodies to intermediate filament proteins in human visceral leishmaniasis and their induction by experimental polyclonal B-cell activation. Immunology 1986; 59 (4):583-8.
7. Bunn-Moreno MM, Madeira ED, Miller K, Menezes JA, Campos-Neto A. Hypergammaglobulinaemia in Leishmania donovani infected hamsters. possible association with a polyclonal activator of B cells and with supression of T cell function. Clin Exp Immunol 1985; 59 (2):427-34.
8. Reina-San-Martin B, Cosson A, Minoprio P. Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Parasitol Today 2000; 16:62-7.
9. McMahon-Pratt D, Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniasis or the visceral disease? Immun Rev 2004; 201:206-24.
10. Casadevall A. Antibody-mediated protection against intracellular pathogens. Trends Microbiol 1998; 6:102-7.
11. Ravindran R, Nahid A. Progress in vaccine research and possible effector mechanism in visceral leishmaniasis. Curr Mol Med 2004; 4:697-709.
12. Monjour L, Berneman A, Vouldoukis I, Domurado M, Guillemin MC, Chopin C, Alfred C, Roseto A. Monoclonal antibodies against defined Leishmania antigens protect mice against infection by different species of Leishmania. CR Acad Sci III 1985; 300 (9):395-8.
13. Yahiaoui B, Taibi A, Ouaissi A. A Leishmania major protein with extensive homology to silent information regulator 2 of Saccharomyces cerevisae. Gene 1996; 169:115-8.
14. Vergnes B, Sereno D, Madjidian-Sereno N, Lemesre JL, Ouaissi A. Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death. Gene 2002; 296:139-50.
15. Vergnes B, Sereno D, Tavares J et al. Targeted disruption of cytosolic SIR2 deacetylase discloses its essential role in Leishmania survival and proliferation. Gene 2005; 363:85-96.
16. Cordeiro-da-Silva A, Cardoso L, Araújo N et al. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications. Immunol Lett 2003; 68:155-62.
17. Sereno D, Roy G, Lemesre JL, Papadopoulou B, Ouellette M. DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antmicrob Agents Chemother 2001; 45:1168-73.
18. Zemzoumi K, Sereno D, Francis C, Guilvard E, Lemesre JL, Ouaissi A. Leishmania major. Cell type dependent distribution of a 43 kDa antigen related to silent information regulatory-2 protein family. Biol Cell 1998; 90:239-45.
19. Lowry OH, Rosebrough NJ, Farr L, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:267-9.
20. Norris KA, Hearth G, So M. Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibody. Infect Immun 1989; 57:2372-7.
21. Roy G, Dumas C, Sereno D et al. Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol 2000; 110:195-206.
22. Baumgarth N. A two-phase of B-cell activation. Immunol Rev 2000; 176:171-80.
23. Pimenta PFP, Saraiva EMB, Sacks D. The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major. Exp Parasitol 1991; 72:191-204.
24. Bjorklund M, Coutinho A. Isotype commitment in the in vivo immune responses. II. Polyclonal plaque-forming cell responses to lipopolysaccharide in the spleen and bone marrow. Euro J Immunol 1983; 13:44-50.
25. Freer G, Burkhart C, Ciernik I, Bachmann MF, Hengartner H, Zinkernagel RM. Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and - independent antigen. J Virol 1994; 68:3650-5.
26. Milich DR, McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 1986; 234:1398-401.
27. Vos Q, Lees A, Wu Z, Snapper CM, Mond JJ. B-cell activation by a T-cell independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganism. Immunol Rev 2000; 176:154-70.
28. Snapper CM, Mond JJ. Towards a comprehensive view of immunoglobulin class switching. Immunol Today 1993; 14:15-7.
29. Mond JJ, Vos Q, Lees A, Snapper CM. T cell independent antigens. Curr Opin Immunol 1995; 7:349-54.
30. Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 2005; 17:282-9.
31. Castigli E, Wilson SA, Scott S et al. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 2005; 201:35-9.
32. Grimaldi GJ, Tesh RB. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbial Rev 1993; 6 (3):230-50.
33. Cordeiro-da-Silva A, Borges MC, Guilvard E, Ouaissi A. Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation. Infect Immun 2001; 69:6588-96.
34. Alexander J, Satoskar AR, Russell DG. Leishmania species: models of intracellular parasitism. J Cell Sci 1999; 112:2993-3002.
35. Wilson ME, Pearson RD. Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infect Immun 1988; 56:363-9.
36. Brittingham A, Chen G, McGwire BS, Chang KP, Mosser DM. Interaction of Leishmania gp63 with cellular receptors for fibronectin. Infect Immun 1999; 67:4477-84.
37. Love DC, Kane MM, Mosser DM. Leishmania amazonensis: the phagocytosis of amastigotes by macrophages. Exp Parasitol 1998; 88 (3):161-71.
38. Dominguez M, Torano A. Immune adherence-mediated opsonophagocytosis. mechanism of Leishmania infection. J Exp Med 1999; 189:25-35.
39. Bogdan C, Röllinghoff M. The immune response to Leishmania: mechanism of parasite control and evasion. Int J Parasitol 1998; 28:121-34.
40. Hall BF, Joiner KA. Strategies of obligate intracellular parasites for evading host defenses. Parasitol Today 1991; 12:A22-A7.
41. Hoover DL, Berger M, Oppenheim MH, Hockmeyer WT, Meltzer MS. Cytotoxicity of human serum for Leishmania donovani amastigotes: antibody facilitation of alternate complement pathway-mediated killing. Infect Immun 1985; 47 (1):247-52.
42. Kima PE, Constant SL, Hannum L, Colmenares M, Lee KS, Haberman AM, Shlomchik MJ, McMahon-Pratt D. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med 2000; 191 (6):1063-7.
43. Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 2000; 273:793-8.
44. Gasser SM, Cockell MM. The molecular biology of the SIR proteins. Gene 2001; 279:1-16.
45. Brachmann CB, Sherman JM, Devine SE, Cameron EE, Pillus L, Boeke JD. The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes Dev 1995; 9:2888-902.
46. Tsukamoto Y, Kato J, Ikeda H. Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae. Nature 1997; 388:900-3.
47. Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 1999; 13:2570-80.
48. Tissenbaum HA, Guarente L. Increased dosage of a Sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001; 410:227-30.
49. Yang YH, Chen YH, Zhang CY, Nimmakayalu MA, Ward DC, Weissman S. Cloning and characterization of two mouse genes with homology to the yeast Sir2 gene. Genomics 2000; 69:355-69.
50. Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: SIR2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 1999; 260:273-9.